Professor Emeritus Mark Hurtig is a at the University of Guelph in Canada which focuses on animal models and translational studies to facilitate regulatory approval of new therapies for clinical use. His work includes industrial and academic collaborations on osteoarthritis mechanisms, identifying disease modifying therapies, and cartilage repair strategies. He work includes collaborations in tissue engineering, computer-assisted surgery, intra-articular medication, biologics and imaging.
